HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $578,386 | +4.6% | 15,141 | -1.3% | 0.01% | +25.0% |
| Q2 2023 | $553,168 | -6.5% | 15,336 | -1.0% | 0.00% | -20.0% |
| Q1 2023 | $591,753 | -34.5% | 15,495 | -2.4% | 0.01% | -28.6% |
| Q4 2022 | $903,401 | +16.3% | 15,877 | -19.3% | 0.01% | 0.0% |
| Q3 2022 | $777,000 | -6.8% | 19,662 | +3.8% | 0.01% | 0.0% |
| Q2 2022 | $834,000 | +11.1% | 18,951 | +0.6% | 0.01% | +40.0% |
| Q1 2022 | $751,000 | -1.6% | 18,838 | -0.8% | 0.01% | 0.0% |
| Q4 2021 | $763,000 | +19.4% | 18,997 | +21.0% | 0.01% | 0.0% |
| Q3 2021 | $639,000 | +4.1% | 15,701 | +16.2% | 0.01% | +25.0% |
| Q2 2021 | $614,000 | +9.3% | 13,510 | +0.2% | 0.00% | 0.0% |
| Q1 2021 | $562,000 | +23.2% | 13,488 | +26.2% | 0.00% | 0.0% |
| Q4 2020 | $456,000 | – | 10,688 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |